癌症患者的药物相关问题:系统性审查
Jayalakshmi Venugopal1, Shalini S1, Rajasekaran A2
1Department of Pharmacy Practice, KMCH College of Pharmacy, Coimbatore, Tamil Nadu, India.
概括
由于多种药物,癌症患者面临与药物相关问题的高风险. 识别年龄和多种药物等风险因素对于有效管理和改善患者护理至关重要.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 患者安全 患者安全
背景情况:
- 癌症患者经常经历与药物相关的问题,由于多药.
- 了解这些问题对于医疗保健提供者来说至关重要,以减少它们的发生.
- 这项研究旨在描述癌症患者的药物相关问题,并探索解决策略.
研究的目的:
- 综合评估癌症患者的药物相关问题.
- 探索解决已识别的与毒品有关的问题的干预措施和行动.
- 建立流行病学研究的基线并确定风险因素.
主要方法:
- 系统性审查遵循系统性审查和元分析 (PRISMA) 准则的首选报告项目.
- 从2015年1月到2023年5月使用电子数据库和医学科目标题 (MeSH) 进行文献搜索.
- 包括来自11个国家的17项研究 (11项前性,6项后性).
主要成果:
- 主要使用的是欧洲药品护理网络的分类系统.
- 与毒品有关的问题的患病率在9.6%至92.8%之间广泛存在.
- 确定的关键预测因素包括患者年龄,多种药物,多种并发症和癌症阶段.
结论:
- 与药物相关的问题在癌症患者中非常普遍.
- 年龄,多种药物,多种并发症和癌症阶段增加了风险.
- 提高认识,早期检测和有效的管理策略对于改善癌症患者护理至关重要.
更多相关视频
相关概念视频
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
246
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
246
Nursing Ethical Principles II
958
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
958
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
274
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
274
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
160
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
160


